Immuneering Corporation (IMRX) vs Korsana Biosciences, Inc. (KRSA)
A side-by-side comparison of Immuneering Corporation and Korsana Biosciences, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
IMRX
Immuneering Corporation
$3.88HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
KRSA
Korsana Biosciences, Inc.
$30.77HealthcareDelayed quote: Oct 6, 2026, 2:45 PM EDT
Total return — IMRX vs KRSA
growth of $100 · dividends reinvested · last 5yIMRX -77.0% (-25.5%/yr)KRSA -92.5% (-40.4%/yr)IMRX compounded faster over this window
IMRX KRSA
IMRX vs KRSA: by the numbers
- •KRSA is the larger company ($144M vs $141M market cap).
- •Both run net losses; IMRX's is the smaller (0.00% vs -353.00% net margin).
Metrics side by side
Valuation
| Metric | IMRX | KRSA |
|---|---|---|
| P/S ratio | N/A | 75.81 |
| P/B ratio | 0.74 | 28.32 |
Profitability
| Metric | IMRX | KRSA |
|---|---|---|
| Gross margin | 0.00% | 100.00% |
| Operating margin | 0.00% | -239.78% |
| Net margin | 0.00% | -353.00% |
| ROE | -30.03% | -131.85% |
| ROIC | -32.73% | -134.15% |
Growth (annualized)
| Metric | IMRX | KRSA |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -11.98% |
| Total return CAGR (5Y) | -32.77% | -40.41% |
Frequently asked
- How have IMRX and KRSA total returns compared?
- Over the past 5 years, IMRX delivered -32.77% and KRSA delivered -40.41% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.